Back to search

Italy· 045489073

TRIMBOW*soluz inal 120 erog 172 mcg + 5 mcg + 9 mcg

A medicinal product containing beclometasone/formoterolo/glicopirronio, registered in Italy by CHIESI FARMACEUTICI SpA, on the national reimbursement list.

Reimbursed in Italy (AIFA class A)

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedTRIMBOW*soluz inal 120 erog 172 mcg +…ATC—REGISTER NO.045489073PACKS LISTED1CHECKEDJune 4, 2026

The record

At a glance

Active substance
Beclometasone/formoterolo/glicopirronio
Manufacturer
CHIESI FARMACEUTICI SpA
Country
Italy (IT)
ATC code
—
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    045489073
    TRIMBOW*soluz inal 120 erog 172 mcg + 5 mcg + 9 mcg
    EUR 72.7

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a10f2cd0-c6ee-4d41-9581-9e6b977fb178
GET /v1/drugs/a10f2cd0-c6ee-4d41-9581-9e6b977fb178?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 72.7,
  "source": "aifa",
  "currency": "EUR",
  "strength": "BECLOMETASONE+FORMOTEROLO+GLICOPIRRONIO 172+5+9MCG 120 DOSI USO RESPIRATORIO",
  "substance": "Beclometasone/formoterolo/glicopirronio",
  "equivalence_group": "MLK",
  "transparency_flag": null
}

See everything about beclometasone/formoterolo/glicopirronio.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.